| Ytd | 220.34% | |
| 1y | 101.06% |
| Open | 3.36 | Prev Close | 3.28 | Low | 3.34 | High | 3.96 | Mkt Cap | 196.56M |
| Vol | 622.63K | Avg Vol | 161.55K | EPS | -0.72 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.07 | Short Ratio | 1.80 | Inst. Own | 10.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-11 | 50-d Avg | 1.74 | 200-d Avg | 1.40 | 1yr Est | 0.00 |
RFL News
Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.08) per share. This is a 57.89 percent i
The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of ca
Rafael Holdings, Inc. (NYSE:RFL) today announced that its subsidiary, Cyclo Therapeutics, has entere
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.13) per share. This is a 31.58 percent i
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent i
Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights relat
Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced revised subscription rights in connection
Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today announced a rights offering, including key dates an
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 416.67 percent
On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' sharehold
Rafael Holdings (NYSE:RFL) reported quarterly earnings of $0.06 per share. This is a 125 percent inc
Continued strong enrollment of pivotal Phase 3 global study (TransportNPC™) evaluating Trappsol® Cyc
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.06) per share. This is a 78.57 percent i
Rafael Holdings, Inc. (NYSE:RFL), today announced that its Board of Directors has authorized the rep
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.14) per share. This is a 16.67 percent d
The most overbought stocks in the real estate sector presents an opportunity to go short on these ov
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.22) per share. This is a 70.67 percent i
Rafael Holdings, Inc. (NYSE:RFL) today announced its decision to curtail its early-stage development
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.24) per share. This is a 68 percent incr
Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said
U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, mea
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.28) per share. This is a 86.67 percent d
Cornerstone Pharmaceuticals, Inc. ("Cornerstone" or the "Company"), a company focus
On Wednesday, 807 companies reached new 52-week lows.
On Monday, 466 companies hit new 52-week lows.
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.12) per share. This is a 71.43 percent d
On Monday, 671 companies achieved new lows for the year.
On Monday, 524 stocks hit new 52-week lows.
On Thursday, 147 companies achieved new lows for the year.
Rafael Pharmaceuticals, Inc. ("Rafael" or the "Company"), a company focused on the
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siya